Basel, Switzerland

Nigel Gains

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nigel Gains. Retrieved from https://idiyas.com/inventor/nigel-gains

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nigel Gains

Introduction

Nigel Gains is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroids that impact cholesterol absorption.

Latest Patents

Nigel Gains holds 1 patent for his innovative work on steroids. His patent involves steroids of the formula ##STR1##, wherein R.sup.1 to R.sup.4, X, and n have specific significance as described. This invention aims to lower intestinal resorption of cholesterol and plasma cholesterol, along with a process for making these steroids from corresponding steroids that have an alcohol residue of the formula --O--X--OH in the 3-position.

Career Highlights

Gains is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of steroid compounds in medical treatments.

Collaborations

Throughout his career, Nigel has collaborated with esteemed colleagues such as Jean-Marie Cassal and Eva-Maria Gutknecht. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Nigel Gains exemplifies the spirit of innovation in the pharmaceutical field through his groundbreaking work on cholesterol-lowering steroids. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…